Which of the following laboratory tests is used to diagnose and monitor the treatment of hemophilia C, a mild bleeding disorder caused by a deficiency of factor XI?

The activated partial thromboplastin time (aPTT) is a laboratory test used to diagnose and monitor the treatment of hemophilia C, as it measures the activity of the intrinsic and common coagulation pathways, which are affected by factor XI deficiency.